MedTrace Logo

INSIGHTS ICD Registry

NCT00279968 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1326

Last updated 2007-12-28

No results posted yet for this study

Summary

The purpose of the Registry is to collect data on how Implantable Cardioverter Defibrillator (ICD) therapies and medications are being used by physicians to treat ventricular arrhythmias in order to better understand how to improve the clinical care of patients and effectiveness of ICD therapies.

Conditions

  • Ventricular Tachycardia
  • Ventricular Fibrillation

Interventions

DEVICE

ICD

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Alfred Buxton, MD · Rhode Island Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-02-29
Completion
2006-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00279968 on ClinicalTrials.gov